This CPB is revised to state that Lupaneta Pack is considered medically necessary for adult women 18 years of age and older with endometriosis who have had a previous treatment with or intolerance to both Lupron Depot (leuprolide acetate) and norethindrone oral tablets. This CPB is revised to state that leuprolide is considered medically necessary for preservation (suppression) of ovarian function in premenopausal women with ER-negative breast cancer receiving chemotherapy. This CPB has been revised to state that degarelix for benign prostatic hyperplasia is considered experimental and investigational.